Kolmar BioTech, Inc. (KOSDAQ:215380)

South Korea · Delayed Price · Currency is KRW

2,360.00

0.00 (0.00%)

At close: Aug 11, 2026

Kolmar BioTech Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	40,304	37,587	43,200	38,616	46,918	31,238
Revenue Growth	-2.54%	-12.99%	11.87%	-17.70%	50.20%	-16.35%
Gross Profit	11,440	10,004	12,586	6,189	6,626	5,748
Operating Income	-1,821	-3,655	1,785	-4,025	-2,521	-3,861
Net Income	-3,677	-5,547	225.3	-5,054	-1,880	-1,926
Earnings Per Share	-220.47	-332.72	15.00	-395.00	-146.00	-161.00
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Infection Control	35,250	30,903	35,531	0.03	33,407
Bio	6,999	7,553	11,387	0.01	3,937
Lab Cloud	951.02	159.56	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	37,087	4,119	4,448	5,746	5,000	6,926
Total Debt	52,797	50,522	50,985	52,316	40,685	39,078
Net Cash (Debt)	-15,710	-46,403	-46,537	-46,570	-35,685	-32,152
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-942.00	-2500.55	-3098.34	-3639.87	-2771.02	-2688.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-3,737	-630.5	-1,126	-3,222	2,502	1,728
Capital Expenditures	-79.45	-253.96	-292.45	-842.88	-11,422	-36,684
Free Cash Flow	-3,817	-884.46	-1,419	-4,065	-8,919	-34,956
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	28.38%	26.61%	29.13%	16.03%	14.12%	18.40%
Operating Margin	-4.52%	-9.72%	4.13%	-10.42%	-5.37%	-12.36%
Pretax Margin	-9.12%	-14.76%	0.52%	-13.09%	-3.98%	-6.16%
Profit Margin	-9.12%	-14.76%	0.52%	-13.09%	-4.01%	-6.17%
FCF Margin	-9.47%	-2.35%	-3.28%	-10.53%	-19.01%	-111.90%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	126.99	-	-	-
PS Ratio	0.99	0.79	0.66	0.70	0.82	2.59